Mizuho believes Tempus AI is being underestimated. The bank initiated the AI-powered health technology firm with an outperform rating and $100 price target, implying an upside of 78% from Wednesday's ...

Tempus AI shares rose after it launched its AI-driven HRD-RNA algorithm to better identify HRD tumors and guide treatment decisions.

Abstract: In this paper, the radiated emission of a microcontroller integrated circuit is investigated by rotating the test board in a transverse electromagnetic (TEM) cell measurement. The dependence ...

Tempus AI, Inc. (NASDAQ:TEM) ranks among the best AI stocks to buy according to analysts. On December 8, TD Cowen reaffirmed its Hold rating on Tempus AI, Inc. (NASDAQ:TEM), with an $88 price target.

Tempus AI TEM is transitioning from a heavy-investment growth stage toward improved operating leverage and a more scalable mix of revenue. This is possible as the company integrates genomics, ...

Spread across 8,200 sq ft on the mall’s ground floor, tem is built as a walk-through space that visitors can explore freely at their own pace without having to go through a guided tour. Toyota ...

Last week, Tempus AI Inc. TEM reported its third-quarter 2025 results. Both earnings and revenues beat their respective consensus estimate. Tempus, a technology company leading the adoption of ...

CANADA - 2025/04/23: In this photo illustration, the Tempus AI logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images) AstraZeneca ...

Tempus AI continues strong revenue growth, driven by its high-margin Data and Services segment and recent Ambry acquisition, but profitability remains elusive. Operational progress is evident, with ...